WEALTH EFFECTS LLC

Position in LLY — ELI LILLY & Co

CIK 1907254 BOSTON, MA

Position in LLY

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$889,977

+$214,866 QoQ

Shares Held

742

+1.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.29%

of 13F equity value

Holder Rank

#3,244

of 4,605 holders

Holding Since

Jun 2022

17 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

WEALTH EFFECTS LLC holds $10,574,441 across 8 Drug Manufacturers - General names. LLY ranks #6 (8.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	10,756	$2,706,639
2	PFE	Pfizer Inc	78,083	$1,880,238
3	JNJ	Johnson & Johnson	6,920	$1,757,472
4	MRK	Merck & Co., Inc.	10,164	$1,306,074
5	AMGN	Amgen Inc	2,905	$1,051,958
6	LLY	ELI LILLY & Co This page	742	$889,977
7	BMY	Bristol Myers Squibb Co	13,775	$793,715
8	OGN	Organon & Co.	13,912	$188,368

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$889,977	742	+1.1%	Shares	Sole	2026-08-06
2026-03-31	$675,111	734	-10.3%	Shares	Sole	2026-04-21
2025-12-31	$879,088	818	-4.6%	Shares	Sole	2026-01-26
2025-09-30	$653,891	857	-19.8%	Shares	Sole	2025-10-28
2025-06-30	$832,538	1,068	-37.5%	Shares	Sole	2025-07-15
2025-03-31	$1,411,480	1,709	-13.6%	Shares	Sole	2025-04-23
2024-12-31	$1,526,244	1,977	-20.4%	Shares	Sole	2025-01-22
2024-09-30	$2,200,674	2,484	-9.3%	Shares	Sole	2024-10-21
2024-06-30	$2,480,741	2,740	-2.6%	Shares	Sole	2024-08-02
2024-03-31	$2,189,179	2,814	-5.9%	Shares	Sole	2024-04-22
2023-12-31	$1,743,513	2,991	+39.1%	Shares	Sole	2024-01-29
2023-09-30	$1,154,829	2,150	+62.9%	Shares	Sole	2023-10-16
2023-06-30	$619,053	1,320	+0.8%	Shares	Sole	2023-07-18
2023-03-31	$449,880	1,310	+27.2%	Shares	Sole	2023-05-04
2022-12-31	$376,815	1,030	+19.1%	Shares	Sole	2023-02-02
2022-09-30	$279,697	865	+20.1%	Shares	Sole	2022-11-14
2022-06-30	$233,445	720	—	Shares	Sole	2022-08-03
No filing history on record for this holder in this stock.